Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL1332530 | 0.95 | — | — | |
| Acetic Acid SCHEMBL8012154 | 0.95 | CA1 (1.00) | — | |
| Acetic Acid SCHEMBL1964006 | 0.95 | CA1 (1.00) | — | |
| Acetic Acid SCHEMBL2289 | 0.95 | — | — | |
| Acetic Acid SCHEMBL1332333 | 0.95 | — | — | |
| Acetic Acid SCHEMBL2343612 | 0.95 | CA1 (1.00) | — | |
| Acetic Acid SCHEMBL10529780 | 0.95 | CA1 (1.00) | — | |
| Acetic Acid SCHEMBL153505 | 0.95 | CA1 (1.00) | — | |
| Acetic Acid SCHEMBL1331799 | 0.95 | — | — | |
| Acetic Acid SCHEMBL72195 | 0.95 | CA1 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108042568-A | The method of dental pulp mescenchymal stem cell blocking property treatment knee joint osteoarthritis | 卡替（上海）生物技术股份有限公司 | 2018-05-18 | — | — | CN | claimed |
| CN-105594660-A | Rat arthralgia and local injection animal model for research on analgesic effect mechanism of peripheral administration of opioids | ZHANG MIAO | 2016-05-25 | — | — | CN | claimed |
| CN-106986857-B | Trk inhibiting compound | 小野药品工业株式会社 | 2019-07-05 | — | — | CN | disclosed |
| CN-106458985-B | 6-heteroaryloxy-and 6-aryloxy-quinoline-2-carboxamides and their use | 艾伯维公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-109073655-A | The method of the amino acid sequence of identification and analysis albumen | 安口生物公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-108289928-A | Improved microbe-binding molecules and uses thereof | 哈佛大学校长及研究员协会 | 2018-07-17 | — | — | CN | disclosed |
| CN-207520368-U | Particle structure of turmeric nutrient fermentation product for preventing and relieving degenerative arthritis | 万宝禄生物科技股份有限公司 | 2018-06-22 | — | — | CN | disclosed |
| CN-108042568-A | The method of dental pulp mescenchymal stem cell blocking property treatment knee joint osteoarthritis | 卡替（上海）生物技术股份有限公司 | 2018-05-18 | — | — | CN | disclosed |
| CN-104284984-B | Rapid antibiotic susceptibility testing | 哈佛大学校长及研究员协会 | 2017-10-13 | — | — | CN | disclosed |
| CN-106986857-A | Trk inhibiting compounds | 小野药品工业株式会社 | 2017-07-28 | — | — | CN | disclosed |
| CN-106928197-A | Trk inhibiting compounds | 小野药品工业株式会社 | 2017-07-07 | — | — | CN | disclosed |
| CN-103037875-B | Bifidobacterium strains | ALIMENTARY HEALTH LIMITE | 2014-11-05 | — | — | CN | disclosed |
| CN-103907025-A | Dialysis like therapeutic (DLT) device | HARVARD COLLEGE | 2014-07-02 | — | — | CN | disclosed |
| CN-101868225-B | Pharmaceutical compositions containing bradykinin antagonists and hyaluronic acid, and uses thereof | LUSO FARMACO INST | 2013-06-12 | — | — | CN | disclosed |
| CN-103037875-A | Bifidobacterium strains | ALIMENTARY HEALTH LIMITE | 2013-04-10 | — | — | CN | disclosed |
| CN-102791272-A | Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient | CATHOLIC UNIV IND ACAD COOP | 2012-11-21 | — | — | CN | disclosed |
| CN-102256628-A | Smart contrast agents for mri imaging | UNIV ROUEN | 2011-11-23 | — | — | CN | disclosed |
| CN-101868225-A | Comprise brad ykinin antagonists and hyaluronic pharmaceutical composition and application thereof | LUSO FARMACO INST | 2010-10-20 | — | — | CN | disclosed |
| CN-100394187-C | Method of assay with sulfonic acid compound and nitro compound | ARKRAY INC (JP) | 2008-06-11 | — | — | CN | disclosed |
| US-5993794-A | CONTAINING 2-7% OF THIOGLYCOLIC ACID, SALT OF THIOGLYCOLIC ACID, CYSTEINE AND/OR ACETYL CYSTEINE AND 1.5-17.5% OF DITHIODIGLYCOLIC ACID, ACID AND/OR CYSTINE | TAKARA BELMONT KABUSHIKI KAISHA (JP) | 1999-11-30 | — | — | US | disclosed |